Skip to main content
. 2020 Jan 18;2020:9238970. doi: 10.1155/2020/9238970

Table 3.

Gene expression associates with clinical outcomes.

Gene expression P value Association with clinical outcome Pathways involved with IBD
↑ IRGM P = 0.001 Medical treatment response to aminosalicylates (5-ASAs) Autophagy
↑ FOXO4 P = 0.05 Histological remission Immune response
↑ CTLA4 P = 0.05 Histological activity index score
↓ SLC26A3 P = 0.001 Clinical course: the course of the same initial activity and prolonged remission Solute transport
↑ SLC39A4 P = 0.0007 Evolution: tendency to years of evolution of between 10 and 15 years
↑ SOD2 P = 0.00004 Severe histological activity Oxidative stress
↑ TDO2 P = 0.06 Clinical course: characterized by the presence of initial activity and then prolonged remission more than 5 years
ALDOB P = 0.005 Evolution: early age at diagnosis of less than 40 years Carbohydrate metabolism
ALDOB P = 0.005 Clinical course: prolonged benign clinical course characterized by the presence of higher initial activity and remission at 5 years